Trial Profile
Phase I single- and multiple-ascending dose trial of intravenous ceftolozane in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Mar 2009
Price :
$35
*
At a glance
- Drugs Ceftolozane (Primary)
- Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections; Urinary tract infections
- Focus Adverse reactions
- Sponsors Calixa Therapeutics
- 31 Mar 2009 New trial record.
- 24 Mar 2009 Results reported in a Calixa Therapeutics media release.